Something for Everyone
Published on
The NDSC conference offers programs that will teach you something new, events where you can meet others who have shared in similar experiences and opportunities for memory making.
Trisomy 21 (Down Syndrome) News and Updates
1 - 10 of 80
What's behind “The Lucky Few” Tattoo?
Published on
The tattoo is meant to be placed in an obvious spot to start a conversation about Down syndrome to spread awareness, promote inclusion, and educate others.
Learning the Latest; Gaining Empowerment
Published on
The annual NDSC Convention provides an opportunity for parents and family members, self-advocates, community advocates and professionals to learn the latest information on Down syndrome.
My Sister Eve
Published on
Having a sister with Down syndrome has taught one young woman more about life than school ever could. She shares her sister's teachings.
Exploring Learning and Memory in Down Syndrome
Published on
Researchers from Drexel University are leading several studies that aim to understand how children with Down syndrome learn and how to most effectively provide early intervention.
New Sleep Study Could Help Children with Down Syndrome
Published on
A new sleep study at CHOP could lead to new treatments for children with Down syndrome who have obstructive sleep apnea.
Participants Sought for Brain Imaging in Down Syndrome Study
Published on
Researchers are recruiting children ages 7-11 for a new research study examining brain development in children with Down syndrome.
Brain Imaging Study Expanded to Include Children with Down Syndrome
Published on
The NIH recently awarded funding for an infant brain imaging study at CHOP to better understand brain and behavioral development in children with Down syndrome.
Down Syndrome: Aidan's Story
Published on
Every day is a new adventure for Aidan, a 1-year-old with Down syndrome who embraces each new challenge with a smile on his face.
Humanized CD19: CAR-T Immunotherapy for First Relapse of ALL in Down Syndrome Patient
Published on
An alternative, humanized CD19 CAR T product for first relapse of pediatric ALL is being evaluated in a clinical trial at Children's Hospital of Philadelphia.